Pacira BioSciences, Inc.
PCRX
$25.24
$0.793.23%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -70.00% | 111.18% | -859.64% | 110.34% | -63.90% |
| Total Depreciation and Amortization | -0.35% | 4.89% | 7.37% | 2.37% | -0.32% |
| Total Amortization of Deferred Charges | -0.12% | 0.58% | 9.80% | 11.49% | -0.56% |
| Total Other Non-Cash Items | -61.74% | -88.91% | 812.62% | 48.17% | -32.79% |
| Change in Net Operating Assets | 105.03% | -1,265.33% | 147.62% | -154.07% | 151.83% |
| Cash from Operations | 7.02% | -38.55% | 1.28% | 8.42% | 3.19% |
| Capital Expenditure | -303.59% | 48.24% | -157.36% | 43.94% | -57.73% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -121.66% | 103.64% | -252.81% | -7.33% | -224.79% |
| Cash from Investing | -6,864.40% | 99.29% | -242.84% | 2.03% | -285.45% |
| Total Debt Issued | -- | -- | -100.00% | -- | -- |
| Total Debt Repaid | -0.04% | 0.04% | 98.61% | -7,096.84% | -0.04% |
| Issuance of Common Stock | -- | -- | -100.00% | -- | -- |
| Repurchase of Common Stock | -135.06% | -140.63% | 99.87% | -634,350.00% | 96.23% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 100.00% | -- | -- |
| Cash from Financing | -53.15% | 31.28% | -111.39% | 986.76% | -58.35% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -77.81% | 2,931.71% | -101.73% | 104.85% | -43.24% |